StockUS listing USERFSFPINKHealthcareValue Trap

Eurofins Scientific SE(ERFSF) Stock Analysis | Healthcare

USD --+0.00%
Reward40Moderate
Risk51Moderate
75%Data
USD —+0.00 (+0.00%) Previous close · PINK
Market cap 13.64Bn
Reward Ratingⓘ40 Moderate reward assessment · 75% data coverage
Bottom 10% of stocksView factors
Risk Ratingⓘ51 Moderate risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on ERFSF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Eurofins Scientific SE?

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide.

AI Brief Pro

The brief on Eurofins Scientific SE

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is Eurofins Scientific SE?

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, training, advisory, and labelling services; biopharma, and clinical diagnostics. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 13.64B, and a P/E ratio of 28.5x.

Financial Highlights

Investment Breakdown

Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
Profitability
Thin or inconsistent margins weigh on earnings quality.
Risk
Risk profile appears balanced versus broad market conditions.
Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (40)

Similar stocks to compare

A short list of Diagnostics & Research names that are close enough in size to make side-by-side comparison useful.

Company Information
SectorHealthcare
IndustryDiagnostics & Research
P/E Ratio28.4888
Beta0.96
Insider Activity
12M windowNo data
No insider activity data available for this ticker.